Profiel
Kean Meng Toh is currently Executive Director, Chief Scientific Officer & VP at CK Life Sciences International (Holdings), Inc. since 2018 and Director at Dogwood Therapeutics, Inc. since 2024.
Formerly, Dr. Toh was Director at Virios Therapeutics, Inc. Education includes undergraduate and doctorate degrees from the National University of Singapore and a graduate degree from the University of London.
Actieve functies van Kean Meng Toh
| Bedrijven | Functie | Begin |
|---|---|---|
| CK LIFE SCIENCES INT'L., (HOLDINGS) INC. | Hoofd Techniek/Wetenschap/O&O | 15-11-2018 |
Eerdere bekende functies van Kean Meng Toh
| Bedrijven | Functie | Einde |
|---|---|---|
Virios Therapeutics, Inc.
Virios Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for fibromyalgia and other related conditions | Directeur/Bestuurslid | - |
Opleiding van Kean Meng Toh
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Virios Therapeutics, Inc.
Virios Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for fibromyalgia and other related conditions | Health Technology |
CK Life Sciences International (Holdings), Inc.
CK Life Sciences International (Holdings), Inc. Pharmaceuticals: OtherHealth Technology Manufactures and markets pharmaceuticals, agriculture and nutraceuticals products | Health Technology |
National University of Singapore
National University of Singapore Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















